Niraparib In Recurrent IDH 1/2 Gliomas
Massachusetts General Hospital
Massachusetts General Hospital
Virginia Commonwealth University
The University of Texas Health Science Center, Houston
Basilea Pharmaceutica
Virginia Commonwealth University
OX2 Therapeutics
OX2 Therapeutics
Children's Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Southern California
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Aposense Ltd.